Your browser doesn't support javascript.
loading
Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib.
Xu, Haojie; Su, Bang; Li, Rong; Wang, Lu; Zhou, Jiaxin; Zhao, Lidan.
Afiliação
  • Xu H; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical, Sciences/Peking Union Medical College, Beijing, China.
  • Su B; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China.
  • Li R; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
  • Wang L; Department of Hand and Foot Surgery, Bethune First Hospital of Jilin University, Changchun, China.
  • Zhou J; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical, Sciences/Peking Union Medical College, Beijing, China.
  • Zhao L; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China.
Int J Rheum Dis ; 27(1): e14899, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37705400
Seronegative rheumatoid arthritis (SNRA) can be a rapid-progressing and highly disabling disease. Anti-PTX3 autoantibody may be a potential biomarker in SNRA diagnosis. SNRA patients could respond well to upadacitinib.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Idioma: En Ano de publicação: 2024 Tipo de documento: Article